{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:43:48Z","timestamp":1793313828860,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020410","name":"Health Institutes of Turkey","doi-asserted-by":"publisher","award":["16876"],"award-info":[{"award-number":["16876"]}],"id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118396","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:00:00Z","timestamp":1764086400000},"page":"118396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and evaluation of novel oxadiazole-based compounds as potential Rac1 inhibitors against breast cancer"],"prefix":"10.1016","volume":"303","author":[{"given":"Ayca","family":"Erdogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilruba","family":"Tirpanlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcin","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enise Ece","family":"Gurdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak","family":"Aru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulderen","family":"Yanikkaya Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7662-9364","authenticated-orcid":false,"given":"Meric","family":"Koksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118396_bib1","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118396_bib2","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.2174\/0929867329666220929145619","article-title":"Oxadiazole derivatives as anticancer and immunomodulatory agents: a systematic review","volume":"30","author":"Mendes Araujo","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib3","first-page":"1","article-title":"Rac1, A potential target for tumor therapy","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118396_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/scbi.2000.0363","article-title":"Lamellipodia in invasion","volume":"11","author":"Condeelis","year":"2001","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2025.118396_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/emboj.2011.481","article-title":"Rac1 gets fattier","volume":"31","author":"Tsai","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118396_bib6","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118396_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114654","article-title":"The Scribble-Rac1 signaling axis drives epithelial cell motility and contributes to diffuse adenomyosis pathogenesis","volume":"450","author":"He","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2025.118396_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2025.05.005","article-title":"Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis","volume":"140","author":"G\u00f6ransson","year":"2025","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2025.118396_bib9","doi-asserted-by":"crossref","first-page":"16378","DOI":"10.1016\/S0021-9258(19)84716-6","article-title":"Rac, a novel ras-related family of proteins that are botulinum toxin substrates","volume":"264","author":"Didsbury","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib10","first-page":"1","article-title":"Rac1: a regulator of cell migration and a potential target for cancer therapy","volume":"28","author":"Ma","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118396_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.trecan.2020.02.021","article-title":"RAC1 as a therapeutic target in malignant melanoma","volume":"6","author":"Cannon","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejmech.2025.118396_bib12","doi-asserted-by":"crossref","first-page":"47530","DOI":"10.1074\/jbc.M108865200","article-title":"Trp56 of Rac1 specifies interaction with a subset of guanine Nucleotide Exchange factors","volume":"276","author":"Gao","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/2589977512666201221162627","article-title":"Significance of 1,3,4-Oxadiazole containing compounds in new drug development","volume":"13","author":"Rana","year":"2020","journal-title":"Curr. Drug. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118396_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138955712801264800","article-title":"1,3,4-Oxadiazole: a biologically active scaffold","volume":"12","author":"Khalilullah","year":"2012","journal-title":"Mini-Reviews Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib15","first-page":"1107","article-title":"Design, synthesis and pharmacological evaluation of 1,3,4-oxadizole derivatives of aryl acetic acid as anti-inflammatory and analgesic agents","volume":"50","author":"Amir","year":"2011","journal-title":"Indian. J. Chem. Sect. B. Org. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib16","first-page":"203","volume":"No. 14\/642","author":"Larsen","year":"2015","journal-title":"U.S. Patent Application"},{"key":"10.1016\/j.ejmech.2025.118396_bib18","series-title":"Oxadiazole Propanamide Compounds for Treating rac-gtpase Mediated Disorder, Application CA2983249A","author":"Williams","year":"2016"},{"key":"10.1016\/j.ejmech.2025.118396_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0854.2009.01015.x","article-title":"The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin \u03b12","volume":"11","author":"Sandrock","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2025.118396_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.cr.7290049","article-title":"DNA fragmentation in apoptosis","volume":"10","author":"Zhang","year":"2000","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118396_bib21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1158\/1535-7163.MCT-09-0906","article-title":"Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein","volume":"9","author":"Yoshida","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2025.118396_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2025.118396_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108110","article-title":"Early-stage structure-based drug discovery for small GTPases by NMR spectroscopy","volume":"236","author":"Yin","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118396_bib24","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1002\/anie.201900585","article-title":"Targeting the small GTPase superfamily through their regulatory proteins","volume":"59","author":"Gray","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118396_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jiec.2021.07.018","article-title":"Current developments in esterification reaction: a review on process and parameters","volume":"103","author":"Khan","year":"2021","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201700153","article-title":"Some novel mannich bases of 5-(3,4-bichlorophenyl)-1,3,4-oxadiazole-2(3H)-one and their anti-inflammatory activity","volume":"350","author":"Koksal","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.118396_bib27","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.bmc.2014.09.048","article-title":"Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorganic. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1556\/1846.2015.00009","article-title":"Flow alkylation of thiols, phenols, and amines using a heterogenous base in a packed-bed reactor","volume":"5","author":"Baker","year":"2015","journal-title":"J. Flow. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib29","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1242\/jcs.062919","article-title":"Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway","volume":"123","author":"Nethe","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2025.118396_bib30","doi-asserted-by":"crossref","first-page":"34586","DOI":"10.18632\/oncotarget.16656","article-title":"Discovery and characterization of small molecule Rac1 inhibitors","volume":"8","author":"Arnst","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118396_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1083\/jcb.200801047","article-title":"Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division","volume":"181","author":"Michaelson","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118396_bib32","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The protein data bank","volume":"58","author":"Berman","year":"2002","journal-title":"Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.118396_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2025.118396_bib35","article-title":"Computational prediction of hot spots and binding site of inhibitor NSC23766 on Rac1 binding with Tiam1","author":"Zheng","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.118396_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/ci100015j","article-title":"ConfGen: a conformational search method for efficient generation of bioactive conformers","volume":"50","author":"Watts","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118396_bib37","unstructured":"The PyMOL Molecular Graphics System, Version 3.0 Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.ejmech.2025.118396_bib38","doi-asserted-by":"crossref","DOI":"10.1063\/1.2191489","article-title":"The midpoint method for parallelization of particle simulations","volume":"124","author":"Bowers","year":"2006","journal-title":"J. Chem. Phys."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:55:41Z","timestamp":1781326541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"alternative-id":["S0223523425011614"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118396","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of novel oxadiazole-based compounds as potential Rac1 inhibitors against breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118396"}}